ImageneBio (IMA) Preferred Shares (2024)
ImageneBio (IMA) posted Preferred Shares of $19.0 million for Q4 2024.
ImageneBio (IMA) Preferred Shares (2024) Analysis & Trends
ImageneBio has reported Preferred Shares for 1 years, with the latest figure at $19.0 million in Q4 2024.
- Quarterly Preferred Shares changed N/A year-over-year to $19.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $19.0 million (changed N/A YoY) and the FY2024 annual result came in at $19.0 million, changed N/A from the prior year.
- Preferred Shares steadied at $19.0 million in Q4 2024 per IMA's latest filing.
- Over five years, Preferred Shares peaked at $19.0 million in Q4 2024 and troughed at $19.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | ImageneBio | 47.41 Mn | -87.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 18.97 Mn |